LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 44 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $211,434 | +1.5% | 213,000 | 0.0% | 0.00% | – |
Q4 2022 | $208,386 | +0.7% | 213,000 | 0.0% | 0.00% | – |
Q3 2022 | $207,000 | +1492.3% | 213,000 | +1538.5% | 0.00% | – |
Q2 2022 | $13,000 | 0.0% | 13,000 | 0.0% | 0.00% | – |
Q1 2022 | $13,000 | 0.0% | 13,000 | 0.0% | 0.00% | – |
Q4 2021 | $13,000 | 0.0% | 13,000 | 0.0% | 0.00% | – |
Q3 2021 | $13,000 | -99.5% | 13,000 | -99.5% | 0.00% | -100.0% |
Q2 2021 | $2,727,000 | +156.5% | 2,763,000 | +166.7% | 0.00% | – |
Q1 2021 | $1,063,000 | -23.0% | 1,036,000 | -31.6% | 0.00% | – |
Q4 2020 | $1,380,000 | -35.2% | 1,515,000 | -35.5% | 0.00% | -100.0% |
Q3 2020 | $2,131,000 | +396.7% | 2,350,000 | +370.0% | 0.00% | – |
Q2 2020 | $429,000 | +10.0% | 500,000 | 0.0% | 0.00% | – |
Q1 2020 | $390,000 | -7.6% | 500,000 | 0.0% | 0.00% | – |
Q4 2019 | $422,000 | +1.2% | 500,000 | 0.0% | 0.00% | – |
Q3 2019 | $417,000 | -50.8% | 500,000 | -50.0% | 0.00% | – |
Q2 2019 | $847,000 | – | 1,000,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|